Abstract
The locus control region (LCR) is a genetic region that regulates the expression of the β-globin locus (HBB locus). This region is composed of several DNase I hypersensitive sites (HSs) in which the regulatory functions of the LCR may reside. To date, some individuals bearing deletions of several HSs or even the complete LCR have been described. Although the globin genes of the HBB locus are intact, most of these patients suffer thalassemia due to the reduced expression of such genes. The LCR and the HSs forming it have been thoroughly studied in different genetic models. However, seemingly contradictory results are often obtained. Here, we describe the first deletion found in humans exclusively affecting the HS3 element of the LCR. The adult carrying this deletion shows very mild hematological modifications, indicating that HS3 deletion does not severely impair the β-gene expression. Our results also reveal limitations of the murine models when studying the native mouse genes for understanding human diseases like thalassemias.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Driscoll, M. C., Dobkin, C. S. & Alter, B. P. Gamma delta beta-thalassemia due to a de novo mutation deleting the 5′ beta-globin gene activation-region hypersensitive sites. Proc. Natl Acad. Sci. USA 86, 7470–7474 (1989).
Fraser, P., Pruzina, S., Antoniou, M. & Grosveld, F. Each hypersensitive site of the human beta-globin locus control region confers a different developmental pattern of expression on the globin genes. Genes Dev. 17, 106–113 (1993).
Kim, S., Kim, Y. W., Shim, S. H., Kim, C. G. & Kim, A. Chromatin structure of the LCR in the human β-globin locus transcribing the adult δ- and β-globin genes. Int. J. Biochem. Cell. Biol. 44, 505–513 (2012).
Peterson, K. R., Clegg, C. H., Navas, P. A., Norton, E. J., Kimbrough, T. G. & Stamatoyannopoulos, G. Effect of deletion of 5′HS3 or 5'HS2 of the human beta-globin locus control region on the developmental regulation of globin gene expression in beta-globin locus yeast artificial chromosome transgenic mice. Proc. Natl Acad. Sci. USA 93, 6605–6609 (1996).
Hug, B. A., Wesselschmidt, R. L., Fiering, S., Bender, M. A., Epner, E., Groudine, M. et al. Analysis of mice containing a targeted deletion of beta-globin locus control region 5′ hypersensitive site 3. Mol. Cell Biol. 16, 2906–2912 (1996).
De la Fuente-Gonzalo, F., Baiget, M., Badell, I., Ricard, P., Vinuesa, L., Martínez-Nieto, J. et al. Study of three families with Hb Agrinio [α29(B10)Leu→Pro, CTG>CCG (α2)] in the Spanish population: three homozygous cases. Hemoglobin 36, 526–532 (2012).
Patrinos, G. P., Giardine, B., Riemer, C., Miller, W., Chui, D. H. K., Anagnou, N. P. et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 32, D537–D541 (2004).
Ellis, J., Tan-Un, K. C., Harper, A., Michalovich, D., Yannoutsos, N., Philipsen, S. et al. A dominant chromatin-opening activity in 5′ hypersensitive site 3 of the human beta-globin locus control region. EMBO J. 15, 562–568 (1996).
Koenig, S. C., Becirevic, E., Hellberg, M. S. C., Li, M. Y., So, J. C. C., Hankins, J. S. et al. Sickle cell disease caused by heterozygosity for Hb S and novel LCR deletion: report of two patients. Am. J. Hematol. 84, 603–606 (2009).
Maragoudaki, E., Kanavakis, E., Traeger-Synodinos, J., Vrettou, C., Tzetis, M., Metaxotou-Mavrommati, A. et al. Molecular, haematological and clinical studies of the -101 C —> T substitution of the beta-globin gene promoter in 25 beta-thalassaemia intermedia patients and 45 heterozygotes. Br. J. Haematol 107, 699–706 (1999).
Peterson, K. R., Fedosyuk, H. & Harju-Baker, S. LCR 5′ hypersensitive site specificity for globin gene activation within the active chromatin hub. Nucleic Acids Res. 40, 11256–11269 (2012).
Bender, M. A., Roach, J. N., Halow, J., Close, J., Alami, R., Bouhassira, E. E. et al. Targeted deletion of 5′HS1 and 5′HS4 of the beta-globin locus control region reveals additive activity of the DNaseI hypersensitive sites. Blood 98, 2022–2027 (2001).
Hu, X., Bulger, M., Bender, M. a., Fields, J., Groudine, M. & Fiering, S. Deletion of the core region of 5′ HS2 of the mouse beta-globin locus control region reveals a distinct effect in comparison with human beta-globin transgenes. Blood 107, 821–826 (2006).
Bender, M. a., Ragoczy, T., Lee, J., Byron, R., Telling, A., Dean, A. et al. The hypersensitive sites of the murine β-globin locus control region act independently to affect nuclear localization and transcriptional elongation. Blood 119, 3820–3827 (2012).
Anguita, E., Sharpe, J. A., Sloane-Stanley, J. A., Tufarelli, C., Higgs, D. R. & Wood, W. G. Deletion of the mouse alpha-globin regulatory element (HS -26) has an unexpectedly mild phenotype. Blood 100, 3450–3456 (2002).
Kulozik, A. E., Bail, S., Bellan-Koch, A., Bartram, C. R., Kohne, E. & Kleihauer, E. The proximal element of the beta globin locus control region is not functionally required in vivo. J. Clin. Invest. 87, 2142–2146 (1991).
Acknowledgements
This work was partially supported by Fondo de Investigación Sanitaria (FIS, PI12/01068 to P Ropero) and co-financed by the Asociación Madrileña de Hematología y Hemoterapia (AMHH).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Nieto, J., Villegas, A., De La Fuente-Gonzalo, F. et al. Heterozygosity for deletion of hypersensitive site 3 in the human locus control region has an unexpected minor effect on red cell phenotype. J Hum Genet 59, 585–587 (2014). https://doi.org/10.1038/jhg.2014.76
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2014.76
